Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Goldberg

Showing results (1001-1010 of 1,004) with videos related to

Pageof 101
Sort By:
You have reached the last page of results.This site can display upto 1,004 results.
Blood|January 10, 2022
A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemiaJohn Mascarenhas, Heidi E Kosiorek, Josef T Prchal, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 26, 2023
Identification of highly selective SIK1/2 inhibitors that modulate innate immune activation and suppress intestinal inflammationHolger Babbe, Thomas B Sundberg, Mark Tichenor, et al.
The Lancet. Haematology|June 22, 2020
Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international expertsAmer M Zeidan, Prajwal C Boddu, Mrinal M Patnaik, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2014
Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant ResearchSally Arai, Mukta Arora, Tao Wang, et al.
Pageof 101

Showing results (1001-1010 of 1,004) with videos related to

Sort By:
Pageof 101
You have reached the last page of results.This site can display upto 1,004 results.
Blood|January 10, 2022
A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemiaJohn Mascarenhas, Heidi E Kosiorek, Josef T Prchal, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 26, 2023
Identification of highly selective SIK1/2 inhibitors that modulate innate immune activation and suppress intestinal inflammationHolger Babbe, Thomas B Sundberg, Mark Tichenor, et al.
The Lancet. Haematology|June 22, 2020
Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international expertsAmer M Zeidan, Prajwal C Boddu, Mrinal M Patnaik, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2014
Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant ResearchSally Arai, Mukta Arora, Tao Wang, et al.
Pageof 101